Apellis Pharmaceuticals Inc (APLS)

Apellis Pharmaceuticals (APLS) Income Statement


Apellis Pharmaceuticals Income Statement

Last quarter (Q1 2023), Apellis Pharmaceuticals's total revenue was $44.85M, an increase of 211.84% from the same quarter last year. In Q1, Apellis Pharmaceuticals's net income was $-177.78M. See Apellis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 105.89M$ 75.42M$ 66.56M$ 250.65M$ 0.00$ 0.00
Cost of Revenue
$ 4.39M$ 5.64M$ 5.20M$ 25.05M$ 0.00-
Gross Profit
$ 101.50M$ 69.79M$ 61.36M$ 225.60M$ 0.00-
Operating Expense
$ 302.34M$ 664.40M$ 597.64M$ 439.32M$ 288.01M$ 127.92M
Operating Income
$ -640.70M$ -594.61M$ -536.28M$ -213.73M$ -288.01M$ -127.92M
Net Non Operating Interest Income Expense
$ -22.80M$ -23.71M$ -12.82M$ -25.77M$ -177.00K$ 447.81K
Other Income Expense
$ -38.00M$ -33.18M$ -196.90M$ -103.53M$ -16.52M$ -25.25K
Pretax Income
$ -691.27M$ -651.50M$ -746.00M$ -343.03M$ -304.71M$ -127.50M
Tax Provision
$ -257.00K$ 669.00K$ 352.00K$ 1.84M$ 0.00-
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -691.01M$ -652.17M$ -746.35M$ -344.87M$ -304.71M$ -127.50M
Basic EPS
$ -6.27$ -6.15$ -8.84$ -4.59$ -4.90$ -2.34
Diluted EPS
$ -6.27$ -6.15$ -8.84$ -4.59$ -4.90$ -2.34
Basic Average Shares
$ 326.50M$ 106.11M$ 84.42M$ 75.16M$ 62.23M$ 54.40M
Diluted Average Shares
$ 326.50M$ 106.11M$ 84.42M$ 75.16M$ 62.23M$ 54.40M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 306.73M$ 670.03M$ 602.84M$ 464.37M$ 288.01M$ 127.92M
Net Income From Continuing And Discontinued Operation
$ -691.01M$ -652.17M$ -746.35M$ -344.87M$ -304.71M$ -127.50M
Normalized Income
$ -493.50M$ -632.44M$ -601.62M$ -269.66M$ -288.37M$ -127.50M
Interest Expense
$ 24.09M$ 32.63M$ 13.24M$ 29.94M$ 5.29M$ 2.51M
$ -659.65M$ -618.88M$ -732.76M$ -313.09M$ -299.42M$ -124.99M
$ -658.03M$ -617.39M$ -731.27M$ -312.23M$ -299.18M$ -124.99M
Currency in USD

Apellis Pharmaceuticals Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis